UC Davis Comprehensive Cancer Center
4501 X Street, 2nd Floor
Sacramento, CA 95817
Additional Phone Numbers
Philosophy of Care
My philosophy of care is to treat every patient how I would want my own family treated. I believe that each patient deserves to be taken care of with compassion, respect, and a commitment to deliver the best care possible. I am dedicated to providing a multidisciplinary approach for my patients bringing together the vast resources of the UC Davis Health System to formulate a shared, patient-centered plan. There is no “simple” operation when you are the patient.
Dr. Campbell is a fellowship-trained endocrine surgeon who specializes in the surgical treatment of patients with thyroid, parathyroid, adrenal and pancreatic disorders. He is an expert in minimally invasive parathyroid and thyroid surgery as well as complex laparoscopic adrenal surgery. He offers a wide range of unique services including transabdominal laparoscopic adrenalectomy; minimally invasive and reoperative thyroid and parathyroid surgery; lymph node dissection using blue dye localization; and ethanol ablation of recurrent thyroid cancer.
Dr. Campbell’s research interests include improving multidisciplinary care for endocrine patients; patient outcomes following thyroid surgery; recurrent and persistent hyperparathyroidism; and familial endocrine disorders (such as multiple endocrine neoplasia).
M.D., UC Davis School of Medicine, Sacramento, California, 2007
B.S., Environmental Toxicology, UC Davis, Davis, California, 1997
General Surgery, Virginia Mason Medical Center, Seattle, Washington, 2012
Endocrine Surgery, UCSF, San Francisco, California, 2013
American Board of Surgery, 2013
American Association of Clinical Endocrinologists
American Association of Endocrine Surgeons (candidate)
American College of Surgeons
Select Recent Publications
Campbell MJ, Seib C and Gosnell JE. Vandetanib and the management of advanced medullary thyroid cancer. Curr Opin Oncol. 2013 Jan;25(1):39-43.
Campbell MJ, Paull NB and Thirlby. Transverse incisions for resection of ileocolic Crohn’s disease. Am Surgeon 2013 Mar;79(3):279-83.
Campbell MJ, Raker E and Farrokhi E. Case report of a hybrid endovascular approach to an abdominal aortic dissection with retrograde thoracic extension and infrarenal aneurysm. J Vasc Endovascular Surg. 2011 Aug; 45(6):561-4.
Roberts JM, Clark CJ, Campbell MJ and Paige KT. Incidence of Abnormal Mammograms after Reduction Mammoplasty: Implications for Oncoplastic Closure. Am J Surg. 2011 May;201(5):608-10
Campbell MJ, Irani S and Olgac S and Chang, L. Laparoscopic Resection of a Gastric Glomus Tumor. In J of Surgery. 2011; 73(3): 270-2.
Campbell MJ, Clark CJ and Paige KT. The role of preoperative mammography in women considering reduction mammoplasty: a single institution review of 207 patients. Am J of Surgery. 2010 May;199(5):636-40.
Campbell MJ and Duh QY. Recurrent and Persistent Hyperparathyroidism. Current Surgical Therapy, 11th Ed. Elsevier Saunders. Philadelphia, PA. 2013.
Campbell MJ and Duh QY. Defining minimally invasive and remote access surgery of the thyroid and parathyroid glands. Robotic and Minimally Invasive Thyroid and Parathyroid Surgery. Springer Publishers. New York, NY. 2013.
Stevane JR, Campbell MJ and Paige KT. Mammographic Screening in the Reduction Mammoplasty Patient. Mammography: Screening, Results and Risks. Nova Publishers; 2012. pp 99-106.
Candell L, Campbell MJ, Shen WT, et al. Ultrasound Guided Methylene Blue Dye Injection for Parathyroid Localization in the Reoperative Neck. World J Surg. 2014 Jan;38(1):88-91
Campbell MJ, McCoy KL, Shen WT et al. A Multi-Institutional International Study of Risk Factors for Hematoma after Thyroidectomy. Surgery. 2013 Dec;154(6):1283-91.